Recent studies show that higher plasma level of soluble ACE2 (sACE2), which are associated with a higher risk for mortality in patients with atrial fibrillation, heart failure and diabetes mellitus, might contribute to improved methods of identifying risk for severe COVID-19 infection [11–13]. The gene discussed is ACE2; the disease is diabetes mellitus.